Brief: MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering
26/06/2023 22:09
June 26 (Reuters) - MoonLake Immunotherapeutics
MLTX.O :
* MOONLAKE IMMUNOTHERAPEUTICS ANNOUNCES PROPOSED
UNDERWRITTEN
PUBLIC OFFERING
* MOONLAKE IMMUNOTHERAPEUTICS - HAS COMMENCED AN
UNDERWRITTEN
PUBLIC OFFERING OF $250 MILLION OF ITS CLASS A ORDINARY SHARES
Source text for Eikon: ID:nGNX9fpkfn
Further company coverage: MLTX.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial